CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and ...
Catheter lock therapy (CLT) may be used in addition to systemic therapy with the aim of reducing treatment failure by targeting biofilm bacteria. A small dose of antimicrobial agent is instilled to ...
A study published in Clinical Infectious Diseases examined the cost-effectiveness of antimicrobial locks for the prevention of central line-associated bloodstream infections. Antibiotic lock therapy ...
Time to catheter failure events in patients receiving Mino-Lok therapy occurred substantially later than in patients in the Control arm. At least one dose of study lock solution demonstrates overall ...
In order to minimize the risk of hemodialysis catheter-related bacteremia (CRB), the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines advocate use of tunneled ...
Antibiotic lock therapy, an alternative treatment for Hickman catheter sepsis, was evaluated in six recipients of prolonged outpatient intravenous therapy. Twenty-two episodes of catheter sepsis were ...
Some antibiotics stop bacteria from growing without actually killing them, allowing infections to return later. Scientists at ...
In our current health care environment, hospitals and health care providers are challenged to provide a high standard of care in a more efficient way. Multiple evidence-based practice guidelines ...
Clinicians have used phages to treat bacterial infections since the early 20 th century. Although the advent and mass production of antibiotics caused a decline in phage therapy, the recent rise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results